GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,986 | -11.8% | 36,620 | 0.0% | 0.00% | – |
| Q2 2023 | $71,409 | -7.4% | 36,620 | +95.6% | 0.00% | – |
| Q1 2022 | $77,151 | -73.0% | 18,726 | -15.9% | 0.00% | – |
| Q4 2021 | $286,000 | +20.7% | 22,257 | +1.3% | 0.00% | – |
| Q3 2021 | $237,000 | +8.7% | 21,969 | -8.1% | 0.00% | – |
| Q2 2021 | $218,000 | +36.2% | 23,904 | +40.8% | 0.00% | – |
| Q1 2021 | $160,000 | +24.0% | 16,975 | -12.0% | 0.00% | – |
| Q2 2020 | $129,000 | +30.3% | 19,300 | +13.8% | 0.00% | – |
| Q1 2020 | $99,000 | -30.8% | 16,960 | +6.7% | 0.00% | – |
| Q4 2019 | $143,000 | 0.0% | 15,895 | -5.9% | 0.00% | – |
| Q3 2019 | $143,000 | -23.5% | 16,892 | +0.6% | 0.00% | – |
| Q2 2019 | $187,000 | – | 16,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |